{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:50:52Z","timestamp":1791294652653,"version":"4.1.0"},"reference-count":261,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-AG031859"],"award-info":[{"award-number":["R01-AG031859"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bright Focus Foundation"},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Sealy Foundation for Biomedical Research"},{"name":"Miriam and Emmett McCoy Foundation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.nbd.2014.09.001","type":"journal-article","created":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T09:57:56Z","timestamp":1410861476000},"page":"92-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"special_numbering":"PA","title":["Insulin resistance in Alzheimer's disease"],"prefix":"10.1016","volume":"72","author":[{"given":"Kelly T.","family":"Dineley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan B.","family":"Jahrling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Denner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2014.09.001_bb0005","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.neurobiolaging.2013.10.076","article-title":"Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition","volume":"35","author":"Adler","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2014.09.001_bb0010","doi-asserted-by":"crossref","first-page":"7918","DOI":"10.1074\/jbc.275.11.7918","volume":"275","author":"Akama","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2014.09.001_bb0015","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1001\/archneur.63.11.1551","article-title":"Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study","volume":"63","author":"Akomolafe","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2014.09.001_bb0020","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging\u2013Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2014.09.001_bb0025","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1517\/14656566.2012.705829","article-title":"Overview of metformin: special focus on metformin extended release","volume":"13","author":"Ali","year":"2012","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.nbd.2014.09.001_bb0030","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/archneur.61.5.661","article-title":"Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function","volume":"61","author":"Arvanitakis","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2014.09.001_bb0035","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/2836","article-title":"The MAPK cascade is required for mammalian associative learning","volume":"1","author":"Atkins","year":"1998","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.001_bb0040","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/archneurol.2010.225","article-title":"Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes","volume":"68","author":"Baker","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2014.09.001_bb0045","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1517\/17460441.2012.666234","article-title":"The value and limitations of transgenic mouse models used in drug discovery for Alzheimer's disease: an update","volume":"7","author":"Bales","year":"2012","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.nbd.2014.09.001_bb0050","doi-asserted-by":"crossref","first-page":"15233","DOI":"10.1073\/pnas.96.26.15233","article-title":"Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease","volume":"96","author":"Bales","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.09.001_bb0055","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3233\/JAD-121711","article-title":"Early selective vulnerability of synapses and synaptic mitochondria in the hippocampal CA1 region of the Tg2576 mouse model of Alzheimer's disease","volume":"34","author":"Balietti","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2014.09.001_bb0060","doi-asserted-by":"crossref","first-page":"C:390","DOI":"10.1016\/j.bbr.2014.08.014","article-title":"Neuroprotective effects of peroxisome proliferator-activated receptor alpha and gamma agonists in model of parkinsonism induced by intranigral 1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine","volume":"274","author":"Barbiero","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2014.09.001_bb0065","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jalz.2012.01.007","article-title":"Fire in the ashes: can failed Alzheimer's disease drugs succeed with second chances?","volume":"9","author":"Becker","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2014.09.001_bb0070","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1471-4159.2004.02722.x","article-title":"MAPK recruitment by beta-amyloid in organotypic hippocampal slice cultures depends on physical state and exposure time","volume":"91","author":"Bell","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.09.001_bb0075","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0197-4580(99)00065-2","article-title":"Evidence for glial-mediated inflammation in aged APP(SW) transgenic mice","volume":"20","author":"Benzing","year":"1999","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2014.09.001_bb0080","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3233\/JAD-2012-121030","article-title":"Increased tau phosphorylation and impaired brain insulin\/IGF signaling in mice fed a high fat\/high cholesterol diet","volume":"36","author":"Bhat","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2014.09.001_bb0085","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.physiol.68.040104.124723","article-title":"From mice to men: insights into the insulin resistance syndromes","volume":"68","author":"Biddinger","year":"2006","journal-title":"Annu. Rev. Physiol."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2014.09.001_bb0090","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S1353-8020(11)70015-3","article-title":"Mild cognitive impairment associated with underlying Alzheimer's disease versus Lewy body disease","volume":"18","author":"Boeve","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2014.09.001_bb0095","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.neurobiolaging.2014.03.029","article-title":"Bexarotene reduces network excitability in models of Alzheimer's disease and epilepsy","volume":"35","author":"Bomben","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2014.09.001_bb0100","first-page":"789","article-title":"Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice","volume":"118","author":"Bonnard","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2014.09.001_bb0105","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1111\/j.1582-4934.2011.01318.x","article-title":"Possible implications of insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis","volume":"15","author":"Bosco","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.nbd.2014.09.001_bb0110","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0083-6729(08)00612-2","article-title":"Serine kinases of insulin receptor substrate proteins","volume":"80","author":"Boura-Halfon","year":"2009","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.nbd.2014.09.001_bb0115","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1046\/j.1471-4159.2002.00990.x","article-title":"Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease","volume":"82","author":"Breidert","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.09.001_bb0120","doi-asserted-by":"crossref","first-page":"223fs8","DOI":"10.1126\/scitranslmed.3008562","article-title":"Sorting the role of SORLA in Alzheimer's disease","volume":"6","author":"Buggia-Prevot","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.nbd.2014.09.001_bb0125","doi-asserted-by":"crossref","first-page":"7988","DOI":"10.1523\/JNEUROSCI.0777-14.2014","article-title":"Genetic reduction of mammalian target of rapamycin ameliorates Alzheimer's disease-like cognitive and pathological deficits by restoring hippocampal gene expression signature","volume":"34","author":"Caccamo","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.001_bb0130","doi-asserted-by":"crossref","first-page":"10908","DOI":"10.1523\/JNEUROSCI.3987-04.2004","article-title":"Peroxisome-proliferator-activated receptor gamma induces a clearance mechanism for the amyloid-beta peptide","volume":"24","author":"Camacho","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.001_bb0135","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.expneurol.2012.05.004","article-title":"Oligomers of beta-amyloid protein (Abeta1-42) induce the activation of cyclooxygenase-2 in astrocytes via an interaction with interleukin-1beta, tumour necrosis factor-alpha, and a nuclear factor kappa-B mechanism in the rat brain","volume":"236","author":"Carrero","year":"2012","journal-title":"Exp. Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2014.09.001_bb0140","first-page":"S405","article-title":"Characterizing the preclinical stages of Alzheimer's disease and the prospect of presymptomatic intervention","volume":"33","author":"Caselli","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2014.09.001_bb0145","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1523\/JNEUROSCI.3192-13.2014","article-title":"Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles","volume":"34","author":"Castillo-Carranza","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.001_bb0150","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s12035-012-8251-3","article-title":"Abeta toxicity in Alzheimer's disease","volume":"45","author":"Cavallucci","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2014.09.001_bb0155","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.bbi.2007.08.014","article-title":"Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system","volume":"22","author":"Chen","year":"2008","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.nbd.2014.09.001_bb0160","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.tem.2010.06.005","article-title":"Insulin signaling meets mitochondria in metabolism","volume":"21","author":"Cheng","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.nbd.2014.09.001_bb0165","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1111\/j.1464-5491.2011.03464.x","article-title":"Insulin resistance and pathological brain ageing","volume":"28","author":"Cholerton","year":"2011","journal-title":"Diabet. Med."},{"key":"10.1016\/j.nbd.2014.09.001_bb0170","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1210\/en.2011-1343","article-title":"NF-kappaB-inducing kinase (NIK) mediates skeletal muscle insulin resistance: blockade by adiponectin","volume":"152","author":"Choudhary","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.nbd.2014.09.001_bb0175","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1523\/JNEUROSCI.20-02-00558.2000","article-title":"Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists","volume":"20","author":"Combs","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.001_bb0180","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11481-011-9313-4","article-title":"Cognitive and behavioral consequences of impaired immunoregulation in aging","volume":"7","author":"Corona","year":"2012","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.nbd.2014.09.001_bb0185","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.neuropharm.2005.03.009","article-title":"Agonists of peroxisome proliferator-activated receptor-gamma attenuate the Abeta-mediated impairment of LTP in the hippocampus in vitro","volume":"49","author":"Costello","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2014.09.001_bb0195","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/archneurol.2009.27","article-title":"The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged","volume":"66","author":"Craft","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2014.09.001_bb0200","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nrneurol.2012.112","article-title":"Alzheimer disease: insulin resistance and AD\u2014extending the translational path","volume":"8","author":"Craft","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2014.09.001_bb0235","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1474-4422(04)00681-7","article-title":"Insulin and neurodegenerative disease: shared and specific mechanisms","volume":"3","author":"Craft","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2014.09.001_bb0230","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1212\/WNL.50.1.164","article-title":"Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype","volume":"50","author":"Craft","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2014.09.001_bb0210","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1001\/archpsyc.56.12.1135","article-title":"Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose","volume":"56","author":"Craft","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.nbd.2014.09.001_bb0215","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000054469","article-title":"Insulin metabolism in Alzheimer's disease differs according to apolipoprotein E genotype and gender","volume":"70","author":"Craft","year":"1999","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.nbd.2014.09.001_bb0205","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0306-4530(02)00087-2","article-title":"Insulin dose\u2013response effects on memory and plasma amyloid precursor protein in Alzheimer's disease: interactions with apolipoprotein E genotype","volume":"28","author":"Craft","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.nbd.2014.09.001_bb0190","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1517\/14728222.9.5.887","article-title":"Neuroinflammation: a potential therapeutic target","volume":"9","author":"Craft","year":"2005","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.nbd.2014.09.001_bb0220","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial","volume":"69","author":"Craft","year":"2012","journal-title":"Arch. Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2014.09.001_bb0225","first-page":"S263","article-title":"Insulin and Alzheimer's disease: untangling the web","volume":"33","author":"Craft","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2014.09.001_bb0240","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1126\/science.1217697","article-title":"ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models","volume":"335","author":"Cramer","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.nbd.2014.09.001_bb0245","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/clpt.2012.222","article-title":"Using genetics to enable studies on the prevention of Alzheimer's disease","volume":"93","author":"Crenshaw","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.nbd.2014.09.001_bb0250","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.2337\/db13-1954","article-title":"Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease","volume":"63","author":"De Felice","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.nbd.2014.09.001_bb0255","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1073\/pnas.0809158106","article-title":"Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers","volume":"106","author":"De Felice","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.09.001_bb0260","doi-asserted-by":"crossref","first-page":"16725","DOI":"10.1523\/JNEUROSCI.2153-12.2012","article-title":"Cognitive enhancement with rosiglitazone links the hippocampal PPARgamma and ERK MAPK signaling pathways","volume":"32","author":"Denner","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.001_bb0265","first-page":"649","article-title":"Peroxisome proliferator-activated receptors: nuclear control of metabolism","volume":"20","author":"Desvergne","year":"1999","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.nbd.2014.09.001_bb0275","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1523\/JNEUROSCI.21-12-04125.2001","article-title":"Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: in vitro and in vivo mechanisms related to Alzheimer's disease","volume":"21","author":"Dineley","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.001_bb0280","doi-asserted-by":"crossref","first-page":"22768","DOI":"10.1074\/jbc.M200164200","article-title":"Accelerated plaque accumulation, associative learning deficits, and up-regulation of alpha 7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins","volume":"277","author":"Dineley","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2014.09.001_bb0270","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.nlm.2007.03.010","article-title":"Acute inhibition of calcineurin restores associative learning and memory in Tg2576 APP transgenic mice","volume":"88","author":"Dineley","year":"2007","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.nbd.2014.09.001_bb0285","doi-asserted-by":"crossref","first-page":"8336","DOI":"10.1523\/JNEUROSCI.0540-14.2014","article-title":"CNS amyloid-beta, soluble APP-alpha and -beta kinetics during BACE inhibition","volume":"34","author":"Dobrowolska","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.001_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2014.04.513","article-title":"Biomarker progressions explain higher variability in stage-specific cognitive decline than baseline values in Alzheimer disease","author":"Dodge","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2014.09.001_bb0295","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.diabres.2012.05.013","article-title":"Type 2 diabetes and\/or its treatment leads to less cognitive impairment in Alzheimer's disease patients","volume":"98","author":"Dominguez","year":"2012","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.nbd.2014.09.001_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2014.05.021","article-title":"Stage-specific changes in neurogenic and glial markers in Alzheimer's disease","author":"Ekonomou","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2014.09.001_bb0305","doi-asserted-by":"crossref","first-page":"24329","DOI":"10.1074\/jbc.271.40.24329","article-title":"Activation of p42 mitogen-activated protein kinase in hippocampal long term potentiation","volume":"271","author":"English","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2014.09.001_bb0310","doi-asserted-by":"crossref","first-page":"19103","DOI":"10.1074\/jbc.272.31.19103","article-title":"A requirement for the mitogen-activated protein kinase cascade in hippocampal long term potentiation","volume":"272","author":"English","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2014.09.001_bb0320","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bbrc.2008.12.071","article-title":"Rosiglitazone reverses memory decline and hippocampal glucocorticoid receptor down-regulation in an Alzheimer's disease mouse model","volume":"379","author":"Escribano","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2014.09.001_bb0315","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/npp.2010.32","article-title":"Rosiglitazone rescues memory impairment in Alzheimer's transgenic mice: mechanisms involving a reduced amyloid and tau pathology","volume":"35","author":"Escribano","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2014.09.001_bb0325","doi-asserted-by":"crossref","first-page":"18779","DOI":"10.1074\/jbc.272.30.18779","article-title":"The organization, promoter analysis, and expression of the human PPARgamma gene","volume":"272","author":"Fajas","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2014.09.001_bb0330","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1073\/pnas.0230450100","article-title":"Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo","volume":"100","author":"Farris","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.09.001_bb0335","first-page":"129","article-title":"The selfish brain: competition for energy resources","volume":"153","author":"Fehm","year":"2006"},{"key":"10.1016\/j.nbd.2014.09.001_bb0340","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/152091503763816481","article-title":"Therapeutic potential of peroxisome proliferator-activated receptor agonists for neurological disease","volume":"5","author":"Feinstein","year":"2003","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.nbd.2014.09.001_bb0345","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrn3209","article-title":"The many faces of insulin-like peptide signalling in the brain","volume":"13","author":"Fernandez","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.001_bb0350","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1016\/j.jalz.2013.12.010","article-title":"Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease","volume":"10","author":"Ferreira","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2014.09.001_bb0355","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/156720511794604561","article-title":"Transgenic mice as a model of pre-clinical Alzheimer's disease","volume":"8","author":"Ferretti","year":"2011","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.nbd.2014.09.001_bb0360","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1523\/JNEUROSCI.21-08-02561.2001","article-title":"Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling","volume":"21","author":"Gasparini","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.001_bb0365","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1477-5956-12-24","article-title":"Recovery of brain biomarkers following peroxisome proliferator-activated receptor agonist neuroprotective treatment before ischemic stroke","volume":"12","author":"Gele","year":"2014","journal-title":"Proteome Sci."},{"key":"10.1016\/j.nbd.2014.09.001_bb0370","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.1523\/JNEUROSCI.21-18-07053.2001","article-title":"Mitogen-activated protein kinase regulates early phosphorylation and delayed expression of Ca2+\/calmodulin-dependent protein kinase II in long-term potentiation","volume":"21","author":"Giovannini","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.001_bb0375","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000318845","article-title":"Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study","volume":"30","author":"Gold","year":"2010","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.nbd.2014.09.001_bb0380","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1046\/j.1460-9568.2003.02694.x","article-title":"Protein kinase C and ERK involvement in dendritic spine plasticity in cultured rodent hippocampal neurons","volume":"17","author":"Goldin","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.001_bb0385","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/jpet.107.125492","article-title":"Ex vivo occupancy of gamma-secretase inhibitors correlates with brain beta-amyloid peptide reduction in Tg2576 mice","volume":"323","author":"Goldstein","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2014.09.001_bb0390","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.neurobiolaging.2012.12.005","article-title":"Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-gamma coactivator 1alpha regulated beta-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models","volume":"34","author":"Gong","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2014.09.001_bb0395","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.biochi.2004.10.019","article-title":"Positive and negative regulation of insulin signaling through IRS-1 phosphorylation","volume":"87","author":"Gual","year":"2005","journal-title":"Biochimie"},{"key":"10.1016\/j.nbd.2014.09.001_bb0400","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuropharm.2011.01.033","article-title":"Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes","volume":"60","author":"Gupta","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2014.09.001_bb0405","doi-asserted-by":"crossref","DOI":"10.1177\/1533317514542644","article-title":"Role of traditional nonsteroidal anti-inflammatory drugs in Alzheimer's disease: a meta-analysis of randomized clinical trials","author":"Gupta","year":"2014","journal-title":"Am. J. Alzheimers Dis. Other Demen."},{"key":"10.1016\/j.nbd.2014.09.001_bb0410","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0028-3932(01)00223-8","article-title":"Impaired fear conditioning in Alzheimer's disease","volume":"40","author":"Hamann","year":"2002","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.nbd.2014.09.001_bb0415","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1532-5415.2009.02067.x","article-title":"Pioglitazone improved cognition in a pilot study on patients with Alzheimer's disease and mild cognitive impairment with diabetes mellitus","volume":"57","author":"Hanyu","year":"2009","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.nbd.2014.09.001_bb0420","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1471-4159.2009.06181.x","article-title":"The amyloid hypothesis for Alzheimer's disease: a critical reappraisal","volume":"110","author":"Hardy","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.09.001_bb0425","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/371161a0","article-title":"Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q","volume":"371","author":"Hashimoto","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2014.09.001_bb0430","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1523\/JNEUROSCI.5038-09.2010","article-title":"Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease","volume":"30","author":"Hernandez","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.001_bb0435","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jalz.2013.01.017","article-title":"Beyond amyloid: getting real about nonamyloid targets in Alzheimer's disease","volume":"9","author":"Herrup","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2014.09.001_bb0440","doi-asserted-by":"crossref","first-page":"e102420","DOI":"10.1371\/journal.pone.0102420","article-title":"The anti-diabetic drug metformin reduces BACE1 protein level by interfering with the MID1 complex","volume":"9","author":"Hettich","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2014.09.001_bb0445","doi-asserted-by":"crossref","first-page":"379024","DOI":"10.1155\/2012\/379024","article-title":"Molecular targets related to inflammation and insulin resistance and potential interventions","volume":"2012","author":"Hirabara","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.nbd.2014.09.001_bb0450","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1096\/fj.03-0978fje","article-title":"Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease","volume":"18","author":"Ho","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2014.09.001_bb0455","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1093\/brain\/awn082","article-title":"Fear conditioning in frontotemporal lobar degeneration and Alzheimer's disease","volume":"131","author":"Hoefer","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2014.09.001_bb0460","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.tem.2012.05.007","article-title":"Muscle mitochondria and insulin resistance: a human perspective","volume":"23","author":"Hoeks","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.nbd.2014.09.001_bb0465","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0140-6736(96)09328-2","article-title":"Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study","volume":"349","author":"Hofman","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2014.09.001_bb0470","doi-asserted-by":"crossref","first-page":"e47739","DOI":"10.1371\/journal.pone.0047739","article-title":"Enrichment and stratification for predementia Alzheimer disease clinical trials","volume":"7","author":"Holland","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2014.09.001_bb0475","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.050004797","article-title":"Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease","volume":"97","author":"Holtzman","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.09.001_bb0480","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1073\/pnas.0611314104","article-title":"Spatial navigation deficit in amnestic mild cognitive impairment","volume":"104","author":"Hort","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.09.001_bb0485","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0531-5565(98)00045-X","article-title":"Transgenic mice expressing Alzheimer amyloid precursor proteins","volume":"33","author":"Hsiao","year":"1998","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.nbd.2014.09.001_bb0490","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","article-title":"Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice","volume":"274","author":"Hsiao","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.nbd.2014.09.001_bb0495","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1096\/fj.09-136945","article-title":"Complex environment experience rescues impaired neurogenesis, enhances synaptic plasticity, and attenuates neuropathology in familial Alzheimer's disease-linked APPswe\/PS1DeltaE9 mice","volume":"24","author":"Hu","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2014.09.001_bb0500","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.1523\/JNEUROSCI.3579-13.2014","article-title":"Amyloid deposition is linked to aberrant entorhinal activity among cognitively normal older adults","volume":"34","author":"Huijbers","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.001_bb0505","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.brainres.2008.04.025","article-title":"Rosiglitazone, a PPAR gamma agonist, attenuates inflammation after surgical brain injury in rodents","volume":"1215","author":"Hyong","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2014.09.001_bb0510","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H","article-title":"TNF alpha and the TNF receptor superfamily: structure-function relationship(s)","volume":"50","author":"Idriss","year":"2000","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.nbd.2014.09.001_bb0515","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1532-5415.2012.03916.x","article-title":"Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case\u2013control study","volume":"60","author":"Imfeld","year":"2012","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.nbd.2014.09.001_bb0520","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.yexcr.2004.09.032","article-title":"Peroxisome proliferator-activated receptor gamma is expressed in hippocampal neurons and its activation prevents beta-amyloid neurodegeneration: role of Wnt signaling","volume":"304","author":"Inestrosa","year":"2005","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.nbd.2014.09.001_bb0525","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/00005072-199709000-00002","article-title":"APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1","volume":"56","author":"Irizarry","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2014.09.001_bb0530","doi-asserted-by":"crossref","first-page":"E246","DOI":"10.1210\/jc.2013-3169","article-title":"Intranasal insulin suppresses systemic but not subcutaneous lipolysis in healthy humans","volume":"99","author":"Iwen","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.nbd.2014.09.001_bb0540","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.neuron.2013.12.003","article-title":"Biomarker modeling of Alzheimer's disease","volume":"80","author":"Jack","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2014.09.001_bb0535","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jalz.2011.03.004","article-title":"Introduction to the recommendations from the National Institute on Aging\u2013Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Jack","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2014.09.001_bb0545","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/archneurol.2011.183","article-title":"Evidence for ordering of Alzheimer disease biomarkers","volume":"68","author":"Jack","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2014.09.001_bb0550","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1523\/JNEUROSCI.4024-13.2014","article-title":"PPARgamma recruitment to active ERK during memory consolidation is required for Alzheimer's disease-related cognitive enhancement","volume":"34","author":"Jahrling","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.001_bb0560","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neuron.2008.04.010","article-title":"ApoE promotes the proteolytic degradation of Abeta","volume":"58","author":"Jiang","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2014.09.001_bb0555","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1755-5949.2012.00341.x","article-title":"PPARgamma agonist pioglitazone reverses memory impairment and biochemical changes in a mouse model of type 2 diabetes mellitus","volume":"18","author":"Jiang","year":"2012","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.nbd.2014.09.001_bb0565","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.bmc.2008.04.031","article-title":"Synthesis and biological evaluation of a library of resveratrol analogues as inhibitors of COX-1, COX-2 and NF-kappaB","volume":"17","author":"Kang","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.nbd.2014.09.001_bb0570","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1523\/JNEUROSCI.21-02-00372.2001","article-title":"Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease","volume":"21","author":"Kawarabayashi","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.001_bb0575","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0092-8674(04)00115-1","article-title":"Translational control by MAPK signaling in long-term synaptic plasticity and memory","volume":"116","author":"Kelleher","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2014.09.001_bb0580","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1212\/01.wnl.0000435561.00234.ee","article-title":"Higher glucose levels associated with lower memory and reduced hippocampal microstructure","volume":"81","author":"Kerti","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2014.09.001_bb0585","doi-asserted-by":"crossref","first-page":"21830","DOI":"10.1073\/pnas.0912793107","article-title":"Biguanide metformin acts on tau phosphorylation via mTOR\/protein phosphatase 2A (PP2A) signaling","volume":"107","author":"Kickstein","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.09.001_bb0590","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-137-1-200207020-00009","article-title":"Metformin: an update","volume":"137","author":"Kirpichnikov","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.nbd.2014.09.001_bb0595","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.2337\/db14-0568","article-title":"Insulin action in brain regulates systemic metabolism and brain function","volume":"63","author":"Kleinridders","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.nbd.2014.09.001_bb0600","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejphar.2008.02.049","article-title":"Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review","volume":"585","author":"Kloppenborg","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2014.09.001_bb0605","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2014.09.001_bb0610","article-title":"Pan-PPAR modulation effectively protects APP\/PS1 mice from amyloid deposition and cognitive deficits","author":"Kummer","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2014.09.001_bb0615","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1037\/0735-7044.112.5.1199","article-title":"Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats","volume":"112","author":"Lannert","year":"1998","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.001_bb0620","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1096\/fj.11-199851","article-title":"Identification of oligomers at early stages of tau aggregation in Alzheimer's disease","volume":"26","author":"Lasagna-Reeves","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2014.09.001_bb0625","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/2051-5960-2-56","article-title":"The formation of tau pore-like structures is prevalent and cell specific: possible implications for the disease phenotypes","volume":"2","author":"Lasagna-Reeves","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.nbd.2014.09.001_bb0630","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.cell.2005.01.015","article-title":"Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice","volume":"120","author":"Lazarov","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2014.09.001_bb0640","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000110372","article-title":"Smoking and Alzheimer's disease: a review of the epidemiological evidence","volume":"13","author":"Lee","year":"1994","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.nbd.2014.09.001_bb0635","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1074\/jbc.M111.295451","article-title":"Apolipoprotein E promotes beta-amyloid trafficking and degradation by modulating microglial cholesterol levels","volume":"287","author":"Lee","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2014.09.001_bb0645","first-page":"449","article-title":"Sedentary lifestyle and its relation to cardiovascular risk factors, insulin resistance and inflammatory profile","volume":"67","author":"Leon-Latre","year":"2014","journal-title":"Rev. Esp. Cardiol."},{"key":"10.1016\/j.nbd.2014.09.001_bb0650","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature04533","article-title":"A specific amyloid-beta protein assembly in the brain impairs memory","volume":"440","author":"Lesne","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2014.09.001_bb0655","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/JAD-2006-9102","article-title":"Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease","volume":"9","author":"Lester-Coll","year":"2006","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2014.09.001_bb0660","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/TA.0b013e3182146d66","article-title":"Diabetic patients with traumatic brain injury: insulin deficiency is associated with increased mortality","volume":"70","author":"Ley","year":"2011","journal-title":"J. Trauma"},{"key":"10.1016\/j.nbd.2014.09.001_bb0670","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0306-4522(02)00162-8","article-title":"Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents","volume":"113","author":"Li","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2014.09.001_bb0675","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2337\/db07-0171","article-title":"Alzheimer-like changes in rat models of spontaneous diabetes","volume":"56","author":"Li","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.nbd.2014.09.001_bb0665","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.pbb.2012.03.002","article-title":"Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice","volume":"101","author":"Li","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.nbd.2014.09.001_bb0680","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/jcbfm.2013.82","article-title":"Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer's disease","volume":"33","author":"Lin","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2014.09.001_bb0685","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12017-012-8199-5","article-title":"The diabetes drug liraglutide ameliorates aberrant insulin receptor localisation and signalling in parallel with decreasing both amyloid-beta plaque and glial pathology in a mouse model of Alzheimer's disease","volume":"15","author":"Long-Smith","year":"2013","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.nbd.2014.09.001_bb0690","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00109-013-1112-3","article-title":"Nilotinib-induced autophagic changes increase endogenous parkin level and ubiquitination, leading to amyloid clearance","volume":"92","author":"Lonskaya","year":"2014","journal-title":"J. Mol. Med. (Berl)."},{"key":"10.1016\/j.nbd.2014.09.001_bb0695","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1126\/science.1104343","article-title":"Mitochondrial dysfunction and type 2 diabetes","volume":"307","author":"Lowell","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.nbd.2014.09.001_bb0705","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/aje\/154.7.635","article-title":"Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort","volume":"154","author":"Luchsinger","year":"2001","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.nbd.2014.09.001_bb0700","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1212\/01.WNL.0000140292.04932.87","article-title":"Hyperinsulinemia and risk of Alzheimer disease","volume":"63","author":"Luchsinger","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2014.09.001_bb0710","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1152\/physrev.00014.2003","article-title":"Long-term potentiation and memory","volume":"84","author":"Lynch","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.nbd.2014.09.001_bb0720","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1517\/14728222.2011.594043","article-title":"Nuclear receptors as therapeutic targets for Alzheimer's disease","volume":"15","author":"Mandrekar-Colucci","year":"2011","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.nbd.2014.09.001_bb0715","doi-asserted-by":"crossref","first-page":"10117","DOI":"10.1523\/JNEUROSCI.5268-11.2012","article-title":"Mechanisms underlying the rapid peroxisome proliferator-activated receptor-gamma-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease","volume":"32","author":"Mandrekar-Colucci","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.001_bb0725","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.cmet.2013.12.009","article-title":"The therapeutic potential of nuclear receptor modulators for treatment of metabolic disorders: PPARgamma, RORs, and Rev-erbs","volume":"19","author":"Marciano","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.nbd.2014.09.001_bb0730","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1038\/cddis.2012.189","article-title":"Effects of long-term treatment with pioglitazone on cognition and glucose metabolism of PS1-KI, 3xTg-AD, and wild-type mice","volume":"3","author":"Masciopinto","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.nbd.2014.09.001_bb0735","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1212\/WNL.0b013e3181eee25f","article-title":"Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study","volume":"75","author":"Matsuzaki","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2014.09.001_bb0740","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006239","article-title":"Epidemiology of Alzheimer disease","volume":"2","author":"Mayeux","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.nbd.2014.09.001_bb0745","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1523\/JNEUROSCI.0529-11.2011","article-title":"The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease","volume":"31","author":"McClean","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.001_bb0750","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1742-2094-5-45","article-title":"TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease","volume":"5","author":"McCoy","year":"2008","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2014.09.001_bb0755","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3233\/JAD-2010-1219","article-title":"Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy","volume":"19","author":"McGeer","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2014.09.001_bb0760","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2014.09.001_bb0765","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0736-5748(00)00012-5","article-title":"Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology","volume":"18","author":"Mehlhorn","year":"2000","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.001_bb0770","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1007\/s00125-011-2160-2","volume":"54","author":"Mody","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.nbd.2014.09.001_bb0775","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuroscience.2003.08.064","article-title":"Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS","volume":"123","author":"Moreno","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2014.09.001_bb0780","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/TA.0b013e3181938c5e","article-title":"Stress insulin resistance is a marker for mortality in traumatic brain injury","volume":"66","author":"Mowery","year":"2009","journal-title":"J. Trauma"},{"key":"10.1016\/j.nbd.2014.09.001_bb0785","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/WCO.0b013e32835a30f4","article-title":"Origins of Alzheimer's disease: reconciling cerebrospinal fluid biomarker and neuropathology data regarding the temporal sequence of amyloid-beta and tau involvement","volume":"25","author":"Musiek","year":"2012","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.nbd.2014.09.001_bb0790","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1523\/JNEUROSCI.3413-13.2014","article-title":"Cognitive enhancing treatment with a PPARgamma agonist normalizes dentate granule cell presynaptic function in Tg2576 APP mice","volume":"34","author":"Nenov","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.001_bb0795","doi-asserted-by":"crossref","first-page":"9287","DOI":"10.1523\/JNEUROSCI.3348-08.2008","article-title":"Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist","volume":"28","author":"Nicolakakis","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.001_bb0805","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1038\/srep03754","article-title":"Reduced phosphorylation of brain insulin receptor substrate and Akt proteins in apolipoprotein-E4 targeted replacement mice","volume":"4","author":"Ong","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2014.09.001_bb0800","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11481-011-9282-7","article-title":"Rosiglitazone improves spatial memory and decreases insoluble Abeta(1\u201342) in APP\/PS1 mice","volume":"7","author":"O'Reilly","year":"2012","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.nbd.2014.09.001_bb0810","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","article-title":"Diabetes mellitus and the risk of dementia: The Rotterdam Study","volume":"53","author":"Ott","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2014.09.001_bb0815","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1365-2125.2011.04118.x","article-title":"Calcineurin inhibitors acutely improve insulin sensitivity without affecting insulin secretion in healthy human volunteers","volume":"73","author":"Ozbay","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.nbd.2014.09.001_bb0825","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/archneurol.2009.15","article-title":"Epilepsy and cognitive impairments in Alzheimer disease","volume":"66","author":"Palop","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2014.09.001_bb0820","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.neuron.2007.07.025","article-title":"Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease","volume":"55","author":"Palop","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2014.09.001_bb0835","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3988\/jcn.2011.7.1.10","article-title":"A common pathogenic mechanism linking type-2 diabetes and Alzheimer's disease: evidence from animal models","volume":"7","author":"Park","year":"2011","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.nbd.2014.09.001_bb0830","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0031-9384(99)00220-6","article-title":"Intracerebroventricular insulin enhances memory in a passive-avoidance task","volume":"68","author":"Park","year":"2000","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.nbd.2014.09.001_bb0840","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1503\/cmaj.070796","article-title":"Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease","volume":"178","author":"Patterson","year":"2008","journal-title":"CMAJ"},{"key":"10.1016\/j.nbd.2014.09.001_bb0845","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.nbd.2004.08.003","article-title":"Insulin resistance contributes to aberrant stress responses in the Tg2576 mouse model of Alzheimer's disease","volume":"17","author":"Pedersen","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.09.001_bb0850","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.expneurol.2006.01.018","article-title":"Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice","volume":"199","author":"Pedersen","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2014.09.001_bb0855","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.bbadis.2014.05.025","article-title":"Early alterations in energy metabolism in the hippocampus of APPswe\/PS1dE9 mouse model of Alzheimer's disease","volume":"1842","author":"Pedros","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2014.09.001_bb0860","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3233\/JAD-130842","article-title":"Predicting progression to dementia in elderly subjects with mild cognitive impairment using both cognitive and neuroimaging predictors","volume":"38","author":"Peters","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2014.09.001_bb0865","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.plipres.2011.06.002","article-title":"Cholesterol metabolism in neurons and astrocytes","volume":"50","author":"Pfrieger","year":"2011","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.nbd.2014.09.001_bb0870","doi-asserted-by":"crossref","first-page":"e81828","DOI":"10.1371\/journal.pone.0081828","article-title":"alpha7 Nicotinic receptor-mediated astrocytic gliotransmitter release: Abeta effects in a preclinical Alzheimer's mouse model","volume":"8","author":"Pirttimaki","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2014.09.001_bb0875","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2014.08.011","article-title":"Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-gamma agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease","author":"Pisanu","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.09.001_bb0880","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3233\/JAD-2010-1270","article-title":"Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice","volume":"19","author":"Plaschke","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2014.09.001_bb0885","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-131430","article-title":"Environmental enrichment lessens cognitive decline in APP23 mice without affecting brain sirtuin expression","author":"Polito","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2014.09.001_bb0890","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/ndt\/gfm762","article-title":"The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation","volume":"23","author":"Porrini","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.nbd.2014.09.001_bb0895","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s12640-013-9437-9","article-title":"Role of nuclear receptor on regulation of BDNF and neuroinflammation in hippocampus of beta-amyloid animal model of Alzheimer's disease","volume":"25","author":"Prakash","year":"2014","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.nbd.2014.09.001_bb0900","doi-asserted-by":"crossref","first-page":"17680","DOI":"10.1523\/JNEUROSCI.4740-11.2011","article-title":"Hippocampal hyperactivation associated with cortical thinning in Alzheimer's disease signature regions in non-demented elderly adults","volume":"31","author":"Putcha","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.001_bb0905","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.brainres.2011.01.084","article-title":"Effects of streptozotocin-induced diabetes on tau phosphorylation in the rat brain","volume":"1383","author":"Qu","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2014.09.001_bb0910","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.4088\/JCP.10087co1c","article-title":"Alzheimer's disease: implications of the updated diagnostic and research criteria","volume":"72","author":"Reiman","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.nbd.2014.09.001_bb0915","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2013.12.024","article-title":"Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers","author":"Reitz","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.nbd.2014.09.001_bb0920","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.expneurol.2012.08.012","article-title":"In search of the neuroprotective mechanism of thiazolidinediones in Parkinson's disease","volume":"238","author":"Ridder","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2014.09.001_bb0925","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/sj.tpj.6500369","article-title":"Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease","volume":"6","author":"Risner","year":"2006","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.nbd.2014.09.001_bb0930","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3233\/JAD-2005-8304","article-title":"Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine","volume":"8","author":"Rivera","year":"2005","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2014.09.001_bb0935","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/jnr.20818","article-title":"Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease","volume":"83","author":"Rockenstein","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2014.09.001_bb0940","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.bbr.2010.08.002","article-title":"Rosiglitazone reversal of Tg2576 cognitive deficits is independent of peripheral gluco-regulatory status","volume":"216","author":"Rodriguez-Rivera","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2014.09.001_bb0945","doi-asserted-by":"crossref","first-page":"15472","DOI":"10.1523\/JNEUROSCI.3960-09.2009","article-title":"Brain-derived neurotrophic factor reduces amyloidogenic processing through control of SORLA gene expression","volume":"29","author":"Rohe","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.001_bb0950","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neurobiolaging.2012.02.027","article-title":"Animal systems in the development of treatments for Alzheimer's disease: challenges, methods, and implications","volume":"34","author":"Sabbagh","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2014.09.001_bb0955","first-page":"321","article-title":"Association of apolipoprotein E epsilon 4 allele with sporadic late onset Alzheimer's disease. A meta-analysis","volume":"17","author":"Sadigh-Eteghad","year":"2012","journal-title":"Neurosciences (Riyadh)"},{"key":"10.1016\/j.nbd.2014.09.001_bb0960","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.2337\/db09-1870","article-title":"Downregulation of AMPK accompanies leucine- and glucose-induced increases in protein synthesis and insulin resistance in rat skeletal muscle","volume":"59","author":"Saha","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.nbd.2014.09.001_bb0965","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1471-4159.2011.07331.x","article-title":"AMP-activated protein kinase: a potential player in Alzheimer's disease","volume":"118","author":"Salminen","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.09.001_bb0970","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/414799a","article-title":"Insulin signalling and the regulation of glucose and lipid metabolism","volume":"414","author":"Saltiel","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2014.09.001_bb0975","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ecl.2013.09.009","article-title":"Metabolic syndrome","volume":"43","author":"Samson","year":"2014","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.nbd.2014.09.001_bb0980","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for insulin resistance: common threads and missing links","volume":"148","author":"Samuel","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2014.09.001_bb0985","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1210\/en.2008-0899","article-title":"Expression of peroxisome proliferator-activated receptor-gamma in key neuronal subsets regulating glucose metabolism and energy homeostasis","volume":"150","author":"Sarruf","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.nbd.2014.09.001_bb0990","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.neurobiolaging.2009.10.009","article-title":"Efficacy of PPAR-gamma agonist pioglitazone in mild Alzheimer disease","volume":"32","author":"Sato","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2014.09.001_bb0995","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.expneurol.2010.10.003","article-title":"Pioglitazone attenuates mitochondrial dysfunction, cognitive impairment, cortical tissue loss, and inflammation following traumatic brain injury","volume":"227","author":"Sauerbeck","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2014.09.001_bb1000","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12035-011-8229-6","article-title":"Brain insulin signaling and Alzheimer's disease: current evidence and future directions","volume":"46","author":"Schioth","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2014.09.001_bb1005","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1212\/WNL.0b013e3181ffe4f6","article-title":"Insulin metabolism and the risk of Alzheimer disease: the Rotterdam Study","volume":"75","author":"Schrijvers","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2014.09.001_bb1010","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-2012-111661","article-title":"Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer's disease","author":"Searcy","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2014.09.001_bb1015","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1101\/lm.6.5.478","article-title":"A necessity for MAP kinase activation in mammalian spatial learning","volume":"6","author":"Selcher","year":"1999","journal-title":"Learn. Mem."},{"key":"10.1016\/j.nbd.2014.09.001_bb1020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1101\/lm.37001","article-title":"Mice lacking the ERK1 isoform of MAP kinase are unimpaired in emotional learning","volume":"8","author":"Selcher","year":"2001","journal-title":"Learn. Mem."},{"key":"10.1016\/j.nbd.2014.09.001_bb1025","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/msb.2008.50","article-title":"Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity","volume":"4","author":"Shaham","year":"2008","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.nbd.2014.09.001_bb1030","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/nm.2756","article-title":"NF-kappaB-inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action","volume":"18","author":"Sheng","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2014.09.001_bb1035","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrneurol.2010.130","article-title":"How does diabetes accelerate Alzheimer disease pathology?","volume":"6","author":"Sims-Robinson","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2014.09.001_bb1040","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jss.2013.11.1088","article-title":"Explicit role of peroxisome proliferator-activated receptor gamma in gallic acid-mediated protection against ischemia-reperfusion-induced acute kidney injury in rats","volume":"187","author":"Singh","year":"2014","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.nbd.2014.09.001_bb1045","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2014.05.019","article-title":"Nuclear receptors in neurodegenerative diseases","author":"Skerrett","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.09.001_bb1050","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/archneur.55.7.964","article-title":"Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study","volume":"55","author":"Slooter","year":"1998","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2014.09.001_bb1055","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/exnr.1994.1044","article-title":"Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol","volume":"126","author":"Sparks","year":"1994","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2014.09.001_bb1060","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0022-510X(95)00105-B","article-title":"Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension","volume":"131","author":"Sparks","year":"1995","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2014.09.001_bb1065","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging\u2013Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2014.09.001_bb1070","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease\u2014is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2014.09.001_bb1075","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.physbeh.2004.07.022","article-title":"Insulin and the CNS: effects on food intake, memory, and endocrine parameters and the role of intranasal insulin administration in humans","volume":"83","author":"Stockhorst","year":"2004","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.nbd.2014.09.001_bb1080","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1073\/pnas.1014715108","article-title":"Selective pharmacogenetic inhibition of mammalian target of Rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage","volume":"108","author":"Stoica","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.09.001_bb1085","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","article-title":"Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late\u2013onset Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.09.001_bb1090","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0083-6729(08)00613-4","article-title":"Phosphorylation of IRS proteins Yin\u2013Yang regulation of insulin signaling","volume":"80","author":"Sun","year":"2009","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.nbd.2014.09.001_bb1095","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1742-2094-9-199","article-title":"Pro-inflammatory interleukin-18 increases Alzheimer's disease-associated amyloid-beta production in human neuron-like cells","volume":"9","author":"Sutinen","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2014.09.001_bb1100","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","article-title":"A meta-analysis of cytokines in Alzheimer's disease","volume":"68","author":"Swardfager","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2014.09.001_bb1105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1471-4159.2001.00054.x","article-title":"The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory","volume":"76","author":"Sweatt","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.09.001_bb1110","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.conb.2004.04.001","article-title":"Mitogen-activated protein kinases in synaptic plasticity and memory","volume":"14","author":"Sweatt","year":"2004","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.nbd.2014.09.001_bb1120","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/09540260701797944","article-title":"Prevention of Alzheimer's disease","volume":"19","author":"Szekely","year":"2007","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.nbd.2014.09.001_bb1125","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bbr.2008.12.034","article-title":"Intermediate- and long-term recognition memory deficits in Tg2576 mice are reversed with acute calcineurin inhibition","volume":"200","author":"Taglialatela","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2014.09.001_bb1130","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev.physiol.70.113006.100533","article-title":"Insulin-like signaling, nutrient homeostasis, and life span","volume":"70","author":"Taguchi","year":"2008","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.nbd.2014.09.001_bb1135","doi-asserted-by":"crossref","first-page":"7036","DOI":"10.1073\/pnas.1000645107","article-title":"Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes","volume":"107","author":"Takeda","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.09.001_bb1140","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2014.09.001_bb1145","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.coph.2009.07.004","article-title":"Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation","volume":"9","author":"Tanti","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.nbd.2014.09.001_bb1150","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1089\/neu.2010.1685","article-title":"Pioglitazone reduces secondary brain damage after experimental brain trauma by PPAR-gamma-independent mechanisms","volume":"28","author":"Thal","year":"2011","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.nbd.2014.09.001_bb1155","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jalz.2013.02.003","article-title":"2013 Alzheimer's disease facts and figures","volume":"9","author":"Thies","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2014.09.001_bb1160","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1744-8069-8-5","article-title":"Resveratrol engages AMPK to attenuate ERK and mTOR signaling in sensory neurons and inhibits incision-induced acute and chronic pain","volume":"8","author":"Tillu","year":"2012","journal-title":"Mol. Pain"},{"key":"10.1016\/j.nbd.2014.09.001_bb1165","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.metabol.2012.11.004","article-title":"Insulin resistance: an adaptive mechanism becomes maladaptive in the current environment - an evolutionary perspective","volume":"62","author":"Tsatsoulis","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.nbd.2014.09.001_bb1170","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.tem.2008.08.001","article-title":"Is mitochondrial dysfunction a cause of insulin resistance?","volume":"19","author":"Turner","year":"2008","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.nbd.2014.09.001_bb1175","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.celrep.2013.12.005","article-title":"A paired RNAi and RabGAP overexpression screen identifies Rab11 as a regulator of beta-amyloid production","volume":"5","author":"Udayar","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2014.09.001_bb1180","doi-asserted-by":"crossref","first-page":"re2","DOI":"10.1126\/scisignal.2002165","article-title":"Structural basis for activation and inhibition of class I phosphoinositide 3-kinases","volume":"4","author":"Vadas","year":"2011","journal-title":"Sci. Signal."},{"key":"10.1016\/j.nbd.2014.09.001_bb1185","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1001\/archneurol.2011.670","article-title":"Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and Alzheimer disease: results from the Framingham Heart Study","volume":"69","author":"van Himbergen","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2014.09.001_bb1190","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S1474-4422(12)70206-5","article-title":"Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial","volume":"11","author":"Vellas","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2014.09.001_bb1195","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1111\/j.1460-9568.2006.05037.x","article-title":"Altered PPARgamma expression and activation after transient focal ischemia in rats","volume":"24","author":"Victor","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.001_bb1200","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/jamaneurol.2013.136","article-title":"Seizures and epileptiform activity in the early stages of Alzheimer disease","volume":"70","author":"Vossel","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2014.09.001_bb1205","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1210\/jcem-64-1-190","article-title":"Cerebrospinal fluid insulin levels increase during intravenous insulin infusions in man","volume":"64","author":"Wallum","year":"1987","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.nbd.2014.09.001_bb1210","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuron.2004.09.010","article-title":"Deciphering the molecular basis of memory failure in Alzheimer's disease","volume":"44","author":"Walsh","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2014.09.001_bb1215","doi-asserted-by":"crossref","first-page":"11138","DOI":"10.1074\/jbc.M209108200","article-title":"Persistent ERK phosphorylation negatively regulates cAMP response element-binding protein (CREB) activity via recruitment of CREB-binding protein to pp90RSK","volume":"278","author":"Wang","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2014.09.001_bb1230","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00023210-200317010-00003","article-title":"The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment","volume":"17","author":"Watson","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.nbd.2014.09.001_bb1225","first-page":"950","article-title":"Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study","volume":"13","author":"Watson","year":"2005","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.nbd.2014.09.001_bb1220","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neurobiolaging.2004.11.011","article-title":"Insulin effects on CSF norepinephrine and cognition in Alzheimer's disease","volume":"27","author":"Watson","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2014.09.001_bb1235","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fgene.2014.00088","article-title":"Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models","volume":"5","author":"Webster","year":"2014","journal-title":"Front. Genet."},{"key":"10.1016\/j.nbd.2014.09.001_bb1240","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1210\/endo-121-4-1562","article-title":"Localization and characterization of insulin receptors in rat brain and pituitary gland using in vitro autoradiography and computerized densitometry","volume":"121","author":"Werther","year":"1987","journal-title":"Endocrinology"},{"key":"10.1016\/j.nbd.2014.09.001_bb1245","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1523\/JNEUROSCI.22-05-01858.2002","article-title":"The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease","volume":"22","author":"Westerman","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.001_bb1250","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1126\/science.1092952","article-title":"Insulin signaling in health and disease","volume":"302","author":"White","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.nbd.2014.09.001_bb1255","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1126\/science.280.5363.517","article-title":"Tracking insulin to the mind","volume":"280","author":"Wickelgren","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.nbd.2014.09.001_bb1260","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/alzrt187","article-title":"Evidence for impaired amyloid beta clearance in Alzheimer's disease","volume":"5","author":"Wildsmith","year":"2013","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.nbd.2014.09.001_bb1265","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0896-6273(00)81124-1","article-title":"ERK plays a regulatory role in induction of LTP by theta frequency stimulation and its modulation by beta-adrenergic receptors","volume":"24","author":"Winder","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2014.09.001_bb1270","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2174\/1381612033455323","article-title":"Insulin and the blood\u2013brain barrier","volume":"9","author":"Woods","year":"2003","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.nbd.2014.09.001_bb1275","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/1947601911407328","article-title":"The ERK cascade: distinct functions within various subcellular organelles","volume":"2","author":"Wortzel","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.nbd.2014.09.001_bb1280","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/83976","article-title":"Spaced stimuli stabilize MAPK pathway activation and its effects on dendritic morphology","volume":"4","author":"Wu","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2014.09.001_bb1285","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1101\/lm.027128.112","article-title":"Role of signal transduction crosstalk between adenylyl cyclase and MAP kinase in hippocampus-dependent memory","volume":"19","author":"Xia","year":"2012","journal-title":"Learn. Mem."},{"key":"10.1016\/j.nbd.2014.09.001_bb1290","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1212\/01.WNL.0000140291.86406.D1","article-title":"Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study","volume":"63","author":"Xu","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2014.09.001_bb1295","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.2337\/db14-0287","article-title":"Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease","volume":"63","author":"Yarchoan","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.nbd.2014.09.001_bb1300","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-014-1328-5","article-title":"Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer's disease and tauopathies","author":"Yarchoan","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2014.09.001_bb1305","doi-asserted-by":"crossref","first-page":"e59313","DOI":"10.1371\/journal.pone.0059313","article-title":"Pioglitazone improves cognitive function via increasing insulin sensitivity and strengthening antioxidant defense system in fructose-drinking insulin resistance rats","volume":"8","author":"Yin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2014.09.001_bb1310","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1096\/fj.06-7703com","article-title":"Amyloid beta oligomers induce impairment of neuronal insulin receptors","volume":"22","author":"Zhao","year":"2008","journal-title":"FASEB J."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996114002642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996114002642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T01:30:08Z","timestamp":1565832608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996114002642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":261,"alternative-id":["S0969996114002642"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2014.09.001","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin resistance in Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2014.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}